Glox Therapeutics, founded in February 2023, is the result of collaborative efforts led by Professor Daniel Walker, Professor Colin Kleanthous, and Dr. James Clark. The company aims to capitalize on recent advancements in the understanding of bacteriocin structure and mode of action, which originated from the laboratories of Professors Walker and Kleanthous at the University of Glasgow and the University of Oxford, respectivel...
Glox Therapeutics, founded in February 2023, is the result of collaborative efforts led by Professor Daniel Walker, Professor Colin Kleanthous, and Dr. James Clark. The company aims to capitalize on recent advancements in the understanding of bacteriocin structure and mode of action, which originated from the laboratories of Professors Walker and Kleanthous at the University of Glasgow and the University of Oxford, respectively. Glox Therapeutics is backed by a network of highly experienced scientific advisers and has garnered support and investment from prominent entities such as the Boehringer Ingelheim Venture Fund and Scottish Enterprise.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.